Literature DB >> 16283988

Prevalence of glaucoma in the wroclaw population. The wroclaw epidemiological study.

Maria H Nizankowska1, Radoslaw Kaczmarek.   

Abstract

PURPOSE: Primarily to determine the prevalence of various types of glaucoma and ocular hypertension in Wroclaw inhabitants aged 40-79 years. The second aim of the study was to determine the number of undiagnosed glaucoma cases in this population.
METHODS: A representative group of the Wroclaw population (4853 people aged from 40 to 79 years) was recruited by a proportional simple random sampling selection with stratification. All participants underwent the first, screening-stage examination, which included a medical history interview, intraocular pressure (IOP) measurement, anterior chamber depth assessment by the Van Herrick technique, and optic nerve head (ONH) assessment by means of indirect ophthalmoscopy (Volk's lens), confocal scanning laser ophthalmoscopy with a Heidelberg Retinal Tomograph (HRT) and scanning laser polarimetry by the GDx Nerve Fiber Analyzer (GDx). The second stage, in glaucoma-suspect patients only, included best corrected visual acuity, static perimetry, 24-hour monitoring of IOP, gonioscopy, and full eye examination with mydriasis. Glaucoma was diagnosed by the presence of any two of the following: characteristic morphological changes in the optic disc, glaucomatous visual field abnormalities, and intraocular pressure greater than 21 mmHg.
RESULTS: The overall prevalence of glaucoma was 1.6% (79 subjects). The prevalence increased with age from 0.4% in subjects belonging to the age group 40-49 years to 4.6% in people aged between 70 and 79 years. The prevalence of definite primary open-angle glaucoma was 1.0% (49 subjects). Normal-pressure glaucoma was diagnosed in 13 subjects (0.3%). Ocular hypertension was diagnosed in 92 subjects (1.9%).
CONCLUSION: The prevalence of the different types of glaucoma was similar to that found in other white populations. Among the subjects examined, 79 had various forms of glaucoma and 71% of them had not previously been diagnosed. Undiagnosed glaucoma is a serious public health problem in Poland.

Entities:  

Mesh:

Year:  2005        PMID: 16283988     DOI: 10.1080/09286580500212904

Source DB:  PubMed          Journal:  Ophthalmic Epidemiol        ISSN: 0928-6586            Impact factor:   1.648


  6 in total

1.  Accuracy of the RTVue-100 Fourier-domain optical coherence tomograph in an optic neuropathy screening trial.

Authors:  Anita Garas; Péter Kóthy; Gábor Holló
Journal:  Int Ophthalmol       Date:  2011-03-20       Impact factor: 2.031

2.  Measurement of treatment compliance using a medical device for glaucoma patients associated with intraocular pressure control: a survey.

Authors:  Jean-Philippe Nordmann; Christophe Baudouin; Jean-Paul Renard; Philippe Denis; Antoine Lafuma; Caroline Laurendeau; Viviane Jeanbat; Gilles Berdeaux
Journal:  Clin Ophthalmol       Date:  2010-07-30

3.  Prevalence of primary open angle glaucoma in the last 20 years: a meta-analysis and systematic review.

Authors:  Nan Zhang; Jiaxing Wang; Ying Li; Bing Jiang
Journal:  Sci Rep       Date:  2021-07-02       Impact factor: 4.379

4.  Cerebrospinal fluid pressure decreases with older age.

Authors:  David Fleischman; John P Berdahl; Jana Zaydlarova; Sandra Stinnett; Michael P Fautsch; R Rand Allingham
Journal:  PLoS One       Date:  2012-12-26       Impact factor: 3.240

5.  A Population-based survey of the prevalence and types of glaucoma in Nigeria: results from the Nigeria National Blindness and Visual Impairment Survey.

Authors:  Fatima Kyari; Gabriel Entekume; Mansur Rabiu; Paul Spry; Richard Wormald; Winifred Nolan; Gudlavalleti V S Murthy; Clare E Gilbert
Journal:  BMC Ophthalmol       Date:  2015-12-12       Impact factor: 2.209

6.  Glaucoma and intraocular pressure in EPIC-Norfolk Eye Study: cross sectional study.

Authors:  Michelle P Y Chan; David C Broadway; Anthony P Khawaja; Jennifer L Y Yip; David F Garway-Heath; Jennifer M Burr; Robert Luben; Shabina Hayat; Nichola Dalzell; Kay-Tee Khaw; Paul J Foster
Journal:  BMJ       Date:  2017-09-13
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.